Ashrafi A, Lin Y, Fong A, Islam J, Anderson T, Ganesan S
Cancers (Basel). 2025; 17(5).
PMID: 40075704
PMC: 11898501.
DOI: 10.3390/cancers17050857.
Randrian V, Dhimene A, Pillet A, Evrard C, Elfadel R, Boyer C
BMC Cancer. 2025; 25(1):398.
PMID: 40045328
PMC: 11881360.
DOI: 10.1186/s12885-025-13787-9.
Mo Y, Wei D, Chen X, Zhang Z, Huo W, Wu M
J Glob Health. 2025; 15:04046.
PMID: 39946554
PMC: 11825124.
DOI: 10.7189/jogh.15.04046.
Lindblad K, Bodtcher H, Sorensen D, Rosted E, Kjeldsted E, Christensen H
Digit Health. 2024; 10:20552076241304870.
PMID: 39711737
PMC: 11662310.
DOI: 10.1177/20552076241304870.
Lee E, Cho J
J Rhinol. 2024; 30(2):69-79.
PMID: 39664874
PMC: 11524355.
DOI: 10.18787/jr.2023.00015.
Insights into cancer characteristics among SARS-CoV-2 infected hospitalized patients: a comprehensive analysis from the National Clinical Registry for COVID-19.
Chatterji S, Turuk A, Das P, Bhattacharya S, Mukherjee S, Ghosh P
J Cancer Res Clin Oncol. 2024; 150(11):500.
PMID: 39546022
PMC: 11568054.
DOI: 10.1007/s00432-024-05966-1.
IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.
Guo Y, Shen B, Lou C, Wang L, Li Y
Discov Oncol. 2024; 15(1):599.
PMID: 39470901
PMC: 11522225.
DOI: 10.1007/s12672-024-01483-2.
Prognostic model for gastric cancer patients with COVID-19 and network pharmacology study on treatment by lentinan.
Zhou S, Sun H
Sci Rep. 2024; 14(1):24645.
PMID: 39428405
PMC: 11491479.
DOI: 10.1038/s41598-024-76783-2.
Cuproptosis-associated lncRNA impact prognosis in patients with non-small cell lung cancer co-infected with COVID-19.
Li J, Wang N, Mao G, Wang J, Xiang M, Zhang H
J Cell Mol Med. 2024; 28(17):e70059.
PMID: 39228012
PMC: 11371660.
DOI: 10.1111/jcmm.70059.
Delayed definitive management of localized prostate cancer: what do we know?.
Mohamad O, Li Y, Feng F, Hong J, Wong A, Kouzi Z
Prostate Cancer Prostatic Dis. 2024; .
PMID: 39128937
DOI: 10.1038/s41391-024-00876-2.
Efficacy and results of virtual nursing intervention for cancer patients: A systematic review and meta-analysis.
Fang H, Sun Y, Yu D, Xu Y
Asia Pac J Oncol Nurs. 2024; 11(7):100515.
PMID: 39050110
PMC: 11267009.
DOI: 10.1016/j.apjon.2024.100515.
Turnaround Time of the Hematology Results of Cancer Patients During the COVID-19 Pandemic: An Opportunity to Initiate a Quality Improvement Process.
El Assil A, Benkirane S, El Kettani Y, Cherif Chefchaouni A, Mamad H, Rahali Y
Cureus. 2024; 16(5):e61149.
PMID: 38933641
PMC: 11200148.
DOI: 10.7759/cureus.61149.
Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters.
Almuqrin A, Alotaibi B, Aldali J, Alshalani A, AlSudais H, Aldali H
BMC Infect Dis. 2024; 24(1):576.
PMID: 38862891
PMC: 11167824.
DOI: 10.1186/s12879-024-09485-9.
Autopsy findings in cancer patients infected with SARS-CoV-2 show a milder presentation of COVID-19 compared to non-cancer patients.
Kocsmar E, Kocsmar I, Elamin F, Papai L, Jakab A, Varkonyi T
Geroscience. 2024; 46(6):6101-6114.
PMID: 38691298
PMC: 11493920.
DOI: 10.1007/s11357-024-01163-7.
Impact of the COVID-19 Pandemic on Head and Neck Cancer Management: The Experience of the Maxillo-Facial Surgery Department of a French Regional Referral Center in a High-Incidence Area.
Colin E, Paasche A, Destrez A, Devauchelle B, Bettoni J, Bouquet J
J Clin Med. 2024; 13(8).
PMID: 38673711
PMC: 11050808.
DOI: 10.3390/jcm13082439.
Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients.
Lidenge S, Yalcin D, Bennett S, Ngalamika O, Kweyamba B, Mwita C
Viruses. 2024; 16(3).
PMID: 38543814
PMC: 10975915.
DOI: 10.3390/v16030448.
Silver Nanoparticles In Situ Synthesized and Incorporated in Uniaxial and Core-Shell Electrospun Nanofibers to Inhibit Coronavirus.
de Freitas C, Souza P, Jacinto G, Braga T, Ricken Y, Souza G
Pharmaceutics. 2024; 16(2).
PMID: 38399322
PMC: 10893522.
DOI: 10.3390/pharmaceutics16020268.
Gene crosstalk between COVID-19 and preeclampsia revealed by blood transcriptome analysis.
Chu Y, Li M, Sun M, Wang J, Xin W, Xu L
Front Immunol. 2024; 14:1243450.
PMID: 38259479
PMC: 10800816.
DOI: 10.3389/fimmu.2023.1243450.
Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions.
Peng Y, Wang Z, Zhong R, Mei S, Liu J, Tang L
Cancers (Basel). 2024; 16(2).
PMID: 38254793
PMC: 10813989.
DOI: 10.3390/cancers16020304.
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals.
Delmonte O, Oguz C, Dobbs K, Myint-Hpu K, Palterer B, Abers M
J Allergy Clin Immunol. 2023; 153(6):1655-1667.
PMID: 38154666
PMC: 11162338.
DOI: 10.1016/j.jaci.2023.12.011.
